As society develops and public awareness of health increases, drug safety has become a focus of public concern. In order to strengthen employees’ awareness of drug production quality and enhance their command and use of knowledge on contamination/cross-contamination prevention, Huayi launched the “Production Quality Month Activity” today.
Our Head of Production, Mr. Jia, pointed out the importance of production quality at the launching ceremony. As a crucial link in drug production and supply, we are fully aware of the significant responsibility we bear. Therefore, the “Production Quality Month Activity” was held this month. Since we have passed the MHRA inspection in 2010 and started commercial production for European market, we have consistently adhered to its GMP requirements to standardize the production process. In 2023, Huayi officially started commercial production for Chinese market. Our aim is to further strengthen the quality control throughout the entire drug production process to ensure the safety, efficacy, and reliability of every drug.
During this activity, we aim to enhance the quality awareness of workshop employees, improve their professional skills, and standardize their operations through a variety of events such as quality competitions, quality inspections, and evaluations etc., and jointly contribute to the company’s development.
The safety and quality of drugs are paramount to everyone’s health and well-being. We understand well that each medication carries the trust and expectations of patients. Let us join hands during the “Production Quality Month” activity, exerting continuous efforts to enhance and safeguard drug quality through practical actions, thereby protecting public health. Let’s write a new chapter in the company’s quality management together!